Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CAVA Group, Inc.(CAVA) | 9,507,990 | 6,507,990 | -3,000,000 | $769.20M | $510.75M | 54.85% | -$258.45M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 154,734,327 | 175,156,062 | +20,421,735 | $241.39M | $420.37M | 45.15% | +$178.99M |